NO961993L - Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor - Google Patents

Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor

Info

Publication number
NO961993L
NO961993L NO961993A NO961993A NO961993L NO 961993 L NO961993 L NO 961993L NO 961993 A NO961993 A NO 961993A NO 961993 A NO961993 A NO 961993A NO 961993 L NO961993 L NO 961993L
Authority
NO
Norway
Prior art keywords
nitric oxide
inhibitor
donor
oxytocin
treatment
Prior art date
Application number
NO961993A
Other languages
English (en)
Norwegian (no)
Other versions
NO961993D0 (no
Inventor
Robert E Garfield
Chandra Yallampalli
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO961993D0 publication Critical patent/NO961993D0/no
Publication of NO961993L publication Critical patent/NO961993L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO961993A 1993-11-16 1996-05-15 Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor NO961993L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15249693A 1993-11-16 1993-11-16
PCT/EP1994/003817 WO1995013802A1 (en) 1993-11-16 1994-11-17 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor

Publications (2)

Publication Number Publication Date
NO961993D0 NO961993D0 (no) 1996-05-15
NO961993L true NO961993L (no) 1996-07-12

Family

ID=22543178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961993A NO961993L (no) 1993-11-16 1996-05-15 Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor

Country Status (20)

Country Link
EP (1) EP0730448B1 (pl)
JP (1) JP4015185B2 (pl)
KR (2) KR100358319B1 (pl)
CN (1) CN1108795C (pl)
AT (1) ATE212833T1 (pl)
AU (2) AU8144594A (pl)
BR (1) BR9408067A (pl)
CA (1) CA2176721A1 (pl)
CZ (1) CZ291475B6 (pl)
DE (1) DE69429823T2 (pl)
DK (1) DK0730448T3 (pl)
ES (1) ES2176307T3 (pl)
FI (1) FI962109A7 (pl)
HU (1) HUT74465A (pl)
NO (1) NO961993L (pl)
NZ (1) NZ276105A (pl)
PL (1) PL178174B1 (pl)
PT (1) PT730448E (pl)
SK (1) SK63396A3 (pl)
WO (1) WO1995013802A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811416A (en) * 1994-06-06 1998-09-22 Board Of Regents The University Of Texas System Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
CN1151781C (zh) 1995-03-14 2004-06-02 舍林股份公司 一氧化氮的供体或者一氧化氮的抑制剂调节子宫颈扩张和伸展的用途
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US5898038A (en) * 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
US5910482A (en) * 1996-03-19 1999-06-08 Board Of Regents, The University Of Texas System Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US5906987A (en) * 1997-03-10 1999-05-25 Schering Aktiengesellschaft And Board Of Regents Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
FR2842108B1 (fr) 2002-07-09 2008-05-02 Effik Composes a base d'hormone et de monoxyde d'azote et leur utilisation en obstetrique et en gynecologie
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0603414T3 (da) * 1992-07-01 1997-04-14 Meiji Seika Co (-)-Ritodrin

Also Published As

Publication number Publication date
ES2176307T3 (es) 2002-12-01
KR100358320B1 (ko) 2003-01-24
FI962109L (fi) 1996-07-15
HUT74465A (en) 1996-12-30
FI962109A0 (fi) 1996-05-17
BR9408067A (pt) 1996-12-24
KR100358319B1 (ko) 2002-10-25
FI962109A7 (fi) 1996-07-15
WO1995013802A1 (en) 1995-05-26
KR960705560A (ko) 1996-11-08
AU732532B2 (en) 2001-04-26
EP0730448A1 (en) 1996-09-11
PL178174B1 (pl) 2000-03-31
CZ139096A3 (en) 1996-10-16
PL314465A1 (en) 1996-09-16
DK0730448T3 (da) 2002-04-22
NZ276105A (en) 2001-04-27
CZ291475B6 (cs) 2003-03-12
HU9601299D0 (en) 1996-07-29
DE69429823T2 (de) 2002-08-22
AU8086398A (en) 1998-10-22
CN1135178A (zh) 1996-11-06
NO961993D0 (no) 1996-05-15
SK63396A3 (en) 1997-03-05
AU8144594A (en) 1995-06-06
CA2176721A1 (en) 1995-05-26
DE69429823D1 (de) 2002-03-21
JPH09505068A (ja) 1997-05-20
EP0730448B1 (en) 2002-02-06
CN1108795C (zh) 2003-05-21
PT730448E (pt) 2002-07-31
JP4015185B2 (ja) 2007-11-28
ATE212833T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
NO961993D0 (no) Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor
IS4555A (is) Notkun köfnunarefnisoxíð gjafa eða köfnunarefnisoxíð lata til að tempra leghálsvíkkun og þenslu
ES8301212A1 (es) Procedimiento para la preparacion de derivados de prostaciclina.
Sammour Prostaglandins (PGS)
CA601309A (en) Copolymers of phosphorus-containing polyesters and vinyl monomers
JPS5247697A (en) Super conductor
IL39109A0 (en) Isolation and purification of kallikrein-trypsin inhibitor
Eto et al. On the Gauge of Woolly Knitting (Part 2)
CA604042A (en) Removal of clays from ores using heating under reducing conditions
Matsuo Sasaki, A., Methodology of Economics
CA600365A (en) Insulating refractory arch
AU225041B2 (en) Improvements in or relating to furnaces forthe thermal treatment of hydrocarbons
CA612022A (en) Art of manufacturing cold water dispersible adhesives
AU254223B2 (en) Prevention and removal of maleic acid deposits
JPS5225291A (en) Fixing or tightening fittings for wire, etc.
CA600249A (en) Electric heating furnace and method of heating
CA612330A (en) Heat treatment of steel
CA628445A (en) Heat treatment of steel
AU242338B2 (en) Hot discharging of furnaces
AU3512658A (en) Improvements in or relating to furnaces forthe thermal treatment of hydrocarbons
YU311775A (en) Process for the isolation of the pure inhibitor of neutral proteinases
CA23337S (en) Checker brick primarily for blast stoves
AU798861A (en) Prevention and removal of maleic acid deposits
AU254444B2 (en) Process forthe reduction of iron oxide
AU235253B2 (en) Improvements in or relating to high-frequency furnaces for inductive heating

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application